🌅 Today's Morning Call
|
S&P Futures
7,448.25
▲ +32.75 (+0.44%)
|
Nasdaq Futures
29,390.50
▲ +185.50 (+0.64%)
|
Dow Futures
51,058.00
▲ +205.00 (+0.40%)
|
|
10Y Treasury
4.54%
▲ +0.06%
|
US Dollar
99.93
▼ -0.10 (-0.10%)
|
Bitcoin
$62,876
▼ -$433 (-0.68%)
|
Data as of 8:07 AM ET
Good morning! Monday, June 8th is kicking off with a constructive tone across the board, and there is no shortage of headlines to chew on before the opening bell. From FDA approvals and billion-dollar buyouts to robot trucks hauling snacks across the Southwest, the news flow this morning is genuinely interesting. Here is your morning rundown.
👀 What to Watch Today
Eyes will be on Boeing (BA) as the final report on the Air India Flight 171 crash is expected to drop. That report could carry real weight for the stock, potentially reigniting scrutiny around aircraft safety protocols and regulatory pressure. Traders who hold BA positions should have alerts set and know their risk tolerance heading in.On the M&A front, the UK's Competition and Markets Authority has officially opened a probe into eBay's (EBAY) $1.2 billion acquisition of Depop, originally purchased from Etsy (ETSY). That regulatory cloud could dampen sentiment around the deal and put both names in focus throughout the session.
There are no major U.S. economic data releases on the calendar for Monday, which means the headline-driven stories from the weekend will do most of the heavy lifting for price action today. Expect volume to build around individual movers rather than broad macro swings.
Your Phone Is Smarter Than Your Inbox
Not every market move can wait. Our text alerts deliver the ones that can't. One short alert, straight to your phone, when something is worth seeing now. No fluff. No noise. No charge.
Text Me the Alerts🌏 Overnight Recap
European markets opened the week with a cautious but mostly positive tone, drawing energy from the M&A headlines out of the UK and Italy. Intesa Sanpaolo (ISNPY) made a formal move overnight, launching a full takeover bid for Italy's storied but troubled Banca Monte dei Paschi di Siena. European banking consolidation is back in the spotlight, and that theme is worth watching as it unfolds.Across the Atlantic, Tate and Lyle confirmed it has agreed to a $3.6 billion takeover offer from U.S. food ingredients giant Ingredion, creating what would be a significant player in the global food and beverage supply chain. Shares of Tate and Lyle (TATYF, TATYY) are in focus this morning as markets digest the deal terms.
Asia closed mixed overnight, with no single dominant catalyst driving regional sentiment. The dollar index (DXY) is sitting just below the 100 level at 99.93, a mild softening that tends to provide modest tailwinds for multinationals. Bitcoin slipped slightly to $62,876, continuing its choppy sideways pattern with no clear catalyst to break the range.
Sponsored Content
Silver Is Now a Growth AND Income Play
Silver Is Now a Growth AND Income Play For decades, silver paid nothing. That just changed. One tiny ETF is delivering 20% annualized distributions plus 68% share appreciation in just 5 months.
📊 Pre-Market Movers
Pfizer (PFE) is drawing attention this morning after the FDA approved its drug aimed at preventing bleeding episodes in children with hemophilia. This is a meaningful label expansion into a pediatric population and adds to the company's rare disease portfolio at a time when PFE has been working hard to diversify beyond its COVID-era revenue mix.Nurix Therapeutics (NRIX) is the name to watch for biotech traders today. Roche inked a $2.3 billion deal with the company, putting $700 million on the table upfront to co-develop a blood-cancer therapy. That kind of headline-grabbing partnership tends to send ripples through the broader small-cap biotech space as investors hunt for the next acquisition target.
Meta (META) is also in the pre-market conversation after the company asked a federal court to hold NSO Group in contempt for continuing to violate an injunction protecting WhatsApp users from spyware. While this is not a near-term earnings mover for META, it reinforces the company's aggressive legal posture on privacy and could add to the narrative around platform security heading into the session.
🔍 Today's Watchlist
- BA: Final Air India Flight 171 crash report expected today, watch for regulatory and legal fallout
- PFE: FDA approval of hemophilia drug for children could lift biotech sentiment broadly
- EBAY and ETSY: UK antitrust probe into the Depop deal adds regulatory risk to watch
- 10-Year Treasury at 4.54%: Rising yields could cap upside in rate-sensitive growth names
- NRIX: $700M upfront from Roche in a $2.3B blood-cancer deal could spark biotech M&A momentum
Sponsored Content
The REAL Reason Trump Is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. If you have even a single dollar invested in the U.S. stock market, this is going to directly impact you.
🎯 The Morning Playbook
The setup for Monday is about as constructive as you could hope for on a headline-driven day. Futures are green across all three major indexes, the dollar is soft enough to help multinationals, and a wave of deal-making and regulatory news gives traders plenty of individual stories to work with rather than one overwhelming macro theme.The Boeing report is the wildcard. If the findings are damning, expect the stock to face selling pressure quickly and watch for spillover into aerospace suppliers. On the flip side, the pharma and biotech corner of the market is getting genuine fundamental support today between PFE's approval and the NRIX deal, making that sector worth overweighting on your watchlist this morning.
The best plays today are probably the ones with clear catalysts and defined risk, not broad market bets. Stay nimble, keep position sizes honest given the yield backdrop, and remember that a green futures open does not guarantee a green close. Make it a productive Monday.
📰 Further Reading
How to Claim Pre-IPO Shares of SpaceX (Ad)
Elon Musk is rushing to take Space Exploration Technologies public. The mega IPO could value the company at $1.5 trillion. The transaction could raise $30 billion in capital to fund Elon's new Space Master Plan. Silicon Valley venture capital firms, Wall Street banks, and tech giants are rushing to...
Here's a link to download now
President Trump could be about to make this overlooked ticker soar (Ad)
For years this ticker has been ignored and overlooked. But Larry Benedict — the hedge fund legend who went 20 years without a losing year — says Trump's "Project 2026" could send it on a rally. He predicts hundreds of billions of dollars are about to flow into this single opportunity. It's not AI. N...
Click here to discover the ticker before Trump triggers "Project 2026"
Middle East Conflict Lights Fuse on US Debt Bomb (Ad)
America was already drowning in $38 trillion of debt, but the recent conflict in the Middle East just accelerated the timeline. As oil spikes, a 100-year-old stock market signal that accurately predicted the 2008 and 2020 crashes is flashing a massive "Sell" on dozens of popular U.S. equities. If yo...
Click here to see the 10 popular stocks to dump immediately